Sympathetic nervous system function in HIV-associated adipose redistribution syndrome

AIDS

Volumn 20, Issue 5, 2006, Pages 773-775

  Van Gurp, Petra J ^a   Tack, Cees J ^a   Van Der Valk, Marc ^b   Reiss, Peter ^b   Lenders, Jacques W M ^a   Sweep, Fred C G J ^a   Sauerwein, Hans P ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ARTICLE; AUTONOMIC NERVOUS SYSTEM; DISEASE ASSOCIATION; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; LIPOLYSIS; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SYMPATHETIC TONE;

ADIPOSE TISSUE; CASE-CONTROL STUDIES; EPINEPHRINE; HIV-1; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LIPOLYSIS; MALE; MUSCLE, SKELETAL; NOREPINEPHRINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 33744962868     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000216379.91936.84     Document Type: Article

References (10)

1. Fliers E, Sauerwein HP, Romijn JA, Reiss P, van der Valk M, Kalsbeek A, et al. HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy. Lancet 2003; 362:1758-1760.
2. van der Valk M, Gisolf EH, Reiss P, Wit FW, Japour A, Weverling GJ, Danner SA. Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection. AIDS 2001; 15:847-855.
3. van der Valk M, Reiss P, van Leth FC, Ackermans MT, Endert E, Romijn JA, et al. Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure. J Clin Endocrinol Metab 2002; 87:5066-5071.
4. van der Valk M, Allick G, Weverling GJ, Romijn JA, Ackermans MT, Lange JM, et al. Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients. J Clin Endocrinol Metab 2004; 89:3554-3560.
5. Muller M. Science, medicine, and the future: microdialysis. BMJ 2002; 324:588-591.
6. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 17:719-734.
7. Mittal CM, Wig N, Mishra S, Deepak KK. Heart rate variability in human immunodeficiency virus-positive individuals. Int J Cardiol 2004; 94:1-6.
8. Becker K, Gorlach I, Frieling T, Haussinger D. Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS 1997; 11:751-757.
9. Kreier F, Fliers E, Voshol PJ, Van Eden CG, Havekes LM, Kalsbeek A, et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat - functional implications. J Clin Invest 2002; 110:1243-1250.
10. Lewis W, Day BJ, Copeland WC. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2003; 2:812-822.